Cargando…

Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature

BACKGROUND: Postpancreatectomy hemorrhage (PPH) is the most severe type of complication after pancreatic surgery, although the effect of antithrombotic therapy (ATT) on PPH is largely unknown. The safety and efficacy of chemical thromboprophylaxis for venous thromboembolism (VTE) remains controversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujikawa, Takahisa, Naito, Shigetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362514/
https://www.ncbi.nlm.nih.gov/pubmed/34447821
http://dx.doi.org/10.12998/wjcc.v9.i23.6747
_version_ 1783738179199696896
author Fujikawa, Takahisa
Naito, Shigetoshi
author_facet Fujikawa, Takahisa
Naito, Shigetoshi
author_sort Fujikawa, Takahisa
collection PubMed
description BACKGROUND: Postpancreatectomy hemorrhage (PPH) is the most severe type of complication after pancreatic surgery, although the effect of antithrombotic therapy (ATT) on PPH is largely unknown. The safety and efficacy of chemical thromboprophylaxis for venous thromboembolism (VTE) remains controversial. AIM: To elucidate the effect of ATT on PPH. METHODS: Published articles between 2013 and 2020 were searched from PubMed and Google Scholar, and after careful reviewing of all studies, studies concerning ATT and pancreatic surgery were included. Data such as study design, type of surgical procedures, type of antithrombotic drugs, and surgical outcome were extracted from the studies. RESULTS: Nineteen published articles with a total of 37863 patients who underwent pancreatic surgery were included in the systematic review. Fourteen were cohort studies, with only three being prospective in nature. Two studies demonstrated that in patients receiving chronic ATT, which were mostly managed by heparin bridging, the risk of PPH was higher compared with those without ATT, and one study showed that patients with direct-acting oral anticoagulants managed by heparin bridging had significantly higher postoperative bleeding rates than others. The remaining six studies reported that pancreatic surgery can be safely performed in patients receiving chronic ATT, even under preoperative aspirin continuation. Concerning chemical thromboprophylaxis for VTE, most studies have shown a potentially high risk of PPH in patients undergoing chemical thromboprophylaxis; however, its effectiveness against VTE has not been statistically demonstrated, particularly among Asian patients. CONCLUSION: Pancreatic surgery in chronically ATT-received patients can be safely performed without an increase in the occurrence of PPH, although the safety and efficacy of chemical thromboprophylaxis for VTE during pancreatic surgery is still controversial. Further investigation using reliable studies with good design is required to establish definite protocols or guidelines.
format Online
Article
Text
id pubmed-8362514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-83625142021-08-25 Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature Fujikawa, Takahisa Naito, Shigetoshi World J Clin Cases Systematic Reviews BACKGROUND: Postpancreatectomy hemorrhage (PPH) is the most severe type of complication after pancreatic surgery, although the effect of antithrombotic therapy (ATT) on PPH is largely unknown. The safety and efficacy of chemical thromboprophylaxis for venous thromboembolism (VTE) remains controversial. AIM: To elucidate the effect of ATT on PPH. METHODS: Published articles between 2013 and 2020 were searched from PubMed and Google Scholar, and after careful reviewing of all studies, studies concerning ATT and pancreatic surgery were included. Data such as study design, type of surgical procedures, type of antithrombotic drugs, and surgical outcome were extracted from the studies. RESULTS: Nineteen published articles with a total of 37863 patients who underwent pancreatic surgery were included in the systematic review. Fourteen were cohort studies, with only three being prospective in nature. Two studies demonstrated that in patients receiving chronic ATT, which were mostly managed by heparin bridging, the risk of PPH was higher compared with those without ATT, and one study showed that patients with direct-acting oral anticoagulants managed by heparin bridging had significantly higher postoperative bleeding rates than others. The remaining six studies reported that pancreatic surgery can be safely performed in patients receiving chronic ATT, even under preoperative aspirin continuation. Concerning chemical thromboprophylaxis for VTE, most studies have shown a potentially high risk of PPH in patients undergoing chemical thromboprophylaxis; however, its effectiveness against VTE has not been statistically demonstrated, particularly among Asian patients. CONCLUSION: Pancreatic surgery in chronically ATT-received patients can be safely performed without an increase in the occurrence of PPH, although the safety and efficacy of chemical thromboprophylaxis for VTE during pancreatic surgery is still controversial. Further investigation using reliable studies with good design is required to establish definite protocols or guidelines. Baishideng Publishing Group Inc 2021-08-16 2021-08-16 /pmc/articles/PMC8362514/ /pubmed/34447821 http://dx.doi.org/10.12998/wjcc.v9.i23.6747 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Systematic Reviews
Fujikawa, Takahisa
Naito, Shigetoshi
Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title_full Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title_fullStr Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title_full_unstemmed Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title_short Safety of pancreatic surgery with special reference to antithrombotic therapy: A systematic review of the literature
title_sort safety of pancreatic surgery with special reference to antithrombotic therapy: a systematic review of the literature
topic Systematic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362514/
https://www.ncbi.nlm.nih.gov/pubmed/34447821
http://dx.doi.org/10.12998/wjcc.v9.i23.6747
work_keys_str_mv AT fujikawatakahisa safetyofpancreaticsurgerywithspecialreferencetoantithrombotictherapyasystematicreviewoftheliterature
AT naitoshigetoshi safetyofpancreaticsurgerywithspecialreferencetoantithrombotictherapyasystematicreviewoftheliterature